The national burden of cerebrovascular diseases in Spain: A population-based study using disability-adjusted life years

Medicina Clinica

Volumn 144, Issue 8, 2015, Pages 353-359

  Catalá López, Ferrán ^a,b   De Larrea Baz, Nerea Fernández ^c   Morant Ginestar, Consuelo ^d   Álvarez Martín, Elena ^e   Díaz Guzmán, Jaime ^f   Génova Maleras, Ricard ^g  

^a Department of Medicines for Veterinary Use   (Spain)

^b Fundacion Instituto de Investigacion en Servicios de Salud   (Spain)

^c Red de Investigacion en Servicios de Salud en Enfermedades Cronicas REDISSEC Carlos III   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e UNIVERSIDAD REY JUAN CARLOS   (Spain)

^f Faculty of Education   (Spain)

^g Regional Health Council   (Spain)

Author keywords

Burden of Disease; Cerebrovascular disease; Disability adjusted life years; Spain; Stroke

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CEREBROVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; FEMALE; HUMAN; INCIDENCE; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; PREMATURE MORTALITY; PUBLIC HEALTH SERVICE; SENSITIVITY ANALYSIS; SOCIAL PSYCHOLOGY; SPAIN; ADOLESCENT; AGE DISTRIBUTION; AGED; CEREBROVASCULAR DISORDERS; COST OF ILLNESS; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; QUALITY ADJUSTED LIFE YEAR; SEX RATIO; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; SEX DISTRIBUTION; SPAIN; YOUNG ADULT;

EID: 84933180028     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.11.040     Document Type: Article

References (44)

1. Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology. 2013;80:S5-12.
2. Zorowitz RD, Gillard PJ, Brainin M. Poststroke spasticity: sequelae and burden on stroke survivors and caregivers. Neurology. 2013;80:S45-52.
3. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124:314-23.
4. Bennett DA, Global Burden of Disease Stroke Expert Group. Methodology of the global and regional burden of stroke study. Neuroepidemiology. 2012;38:30-40.
5. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol. 2004;3:391-3.
6. Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4-5.
7. Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull. 2009;92:7-32.
8. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8:345-54.
9. Catalá-López F, Gènova-Maleras R, Vieta E, Tabarés-Seisdedos R. The increasing burden of mental and neurological disorders. Eur Neuropsychopharmacol. 2013, http://dx.doi.org/10.1016/j.euroneuro.2013.04.001. pii: S0924-977X (13) 00119-3.
10. Zhang Y, Chapman AM, Plested M, Jackson D, Purroy F. The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: a literature review. Stroke Res Treat. 2012;2012:436125.
11. Medrano Alberto MJ, Boix Martínez R, Cerrato Crespán E, Ramírez Santa-Pau M. Incidence and prevalence of ischaemic heart disease and cerebrovascular disease in Spain: a systematic review of the literature. Rev Esp Salud Publica. 2006;80:5-15.
12. Instituto Nacional de Estadística. Anonymised death records microdata for the year 2008. Madrid, Spain: Instituto Nacional de Estadística; 2013.
13. Díaz-Guzmán J, Egido JA, Gabriel-Sánchez R, Barberá-Comes G, Fuentes-Gimeno B, Fernández-Pérez C, et al. Stroke and transient ischemic attack incidence rate in Spain: the IBERICTUS study. Cerebrovasc Dis. 2012;34:272-81.
14. Díaz-Guzmán J, Egido-Herrero JA, Gabriel-Sánchez R, Barberà G, Fuentes B, Fernández-Pérez C, et al. Incidence of strokes in Spain: methodological foundations of the Iberictus study. Rev Neurol. 2008;47:617-23.
15. Instituto Nacional de Estadística. Population now-cast for the year 2008. Madrid, Spain: Instituto Nacional de Estadística; 2013.
16. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr. 2003;1:4.
17. Murray CJL, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380:2063-6.
18. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values inassessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129-43.
19. Alzamora MT, Sorribes M, Heras A, Vila N, Vicheto M, Forés R, et al. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain: a communitybased study. BMcNeurol. 2008;8:5.
20. Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 2000;31:1494-501.
21. Murray CJL, Lopez AD. The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2010. Boston: Harvard University Press; 1996.
22. Coale A, Guo G. Revised regional model life tables at very low levels of mortality. Population Index. 1989;55:613-43.
23. Departamento de Salud Internacional, Instituto de Salud Carlos III. GesMor, software, Version 1.1.28. Madrid: Instituto de Salud Carlos III; 2001.
24. Consellería de Sanidade, Xunta de Galicia, Pan American Health Organization (PAHO). Epidat version 4.0. Aná lisis epidemioló gico de datos. Software for epidemiological data analysis. Santiago de Compostela: Consellería de Sanidade, Xunta de Galicia; 2011.
25. Lapostolle A, Lefranc A, Gremy I, Spira A. Sensitivity analysis in summary measure of population health in France. Eur J Public Health. 2007;18:195-200.
26. Catalá-López F, Gènova-Maleras R. Prevention and control of chronic non-communicable diseases in Spain: a call to action. Med Clin (Barc). 2013;140:502-3.
27. Catalá-López F, Alonso-Arroyo A, Aleixandre-Benavent R, Ridao M, Bolaños M, García-Altés A, et al. Coauthorship and institutional collaborations on costeffectiveness analyses: a systematic network analysis. PLoSONE. 2012;7:e38012.
28. Dodhia H, Phillips K, Zannou MI, Airoldi M, Bevan G. Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population. J Hypertens. 2012;30:217-26.
29. Schopper C, Pereira J, Torres A, Cuende N, Alonso M, Baylin A, et al. Estimating the burdenofdiseaseinone Swiss Canton: whatdodisability adjusted life years (DALY) tell us? Int J Epidemiol. 2000;29:871-7.
30. Kominski GF, Simon PA, Ho A, Luck J, Lim YW, Fielding JE. Assessing the burden of disease and injury in Los Angeles county using disability-adjusted life years. Public Health Rep. 2002;117:185-91.
31. Dodhia H, Phillips K. Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years. J Public Health (Oxf). 2008;30:313-21.
32. Gènova-Maleras R, Álvarez-Martín E, Morant-Ginestar C, Fernández De Larrea-Baz N, Catalá-López F. Measuring the burden of disease and injury in Spain using disability-adjusted life years: an updated and policy-oriented overview. Public Health. 2012;126:1024-31.
33. Catalá-López F, Gènova-Maleras R, Ridao M, Alvarez E, Sanfélix-Gimeno G, Morant C, et al. Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study. Med Clin (Barc). 2013;140:343-50.
34. Katzenellenbogen JM, Begg S, Somerford P, Anderson CS, Semmens JB, Codde JP, et al. Disability burden due to stroke in Western Australia: new insights from linked data sources. Int J Stroke. 2010;5:269-77.
35. Bertram MY, Katzenellenbogen J, Vos T, Bradshaw D, Hofman KJ. The disability adjusted life years due to stroke in South Africa in 2008. Int J Stroke. 2013;8 Suppl 100:76-80.
36. Hong KS, Kim J, Cho YJ, Seo SY, Hwang SI, Kim SC, et al. Burden of ischemic stroke in Korea: analysis of disability-adjusted life years lost. J Clin Neurol. 2011;7:77-84.
37. Vlajinac H, Sipetic S, Saulic A, Atanackovic Z, Marinković J, Bjegovic V. Burden of ischaemic heart disease and cerebrovascular diseases in Serbia without Kosovo and Metohia, 2000. Eur J Cardiovasc Prev Rehabil. 2006;13:753-9.
38. Banerjee TK, Dutta S, Ray BK, Ghosal M, Hazra A, Chaudhuri A, Das SK. Disease burden of stroke in Kolkata, India: derivation of disability-adjusted life years by a direct method. Neuroepidemiology. 2013;41:88-93.
39. Chen CY, Huang YB, Tzu-Chi Lee C. Epidemiology and disease burden of ischemic stroke in Taiwan. Int J Neurosci. 2013;123:724-31.
40. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden ofstroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;24, http://dx.doi.org/10.1016/S0140-6736 (13) 61953-4.
41. Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, Tresserras R, Elosua R. The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia. Rev Esp Cardiol. 2007;60:573-80.
42. Spanish Ministry of Health, Social Policy and Equality. Quality Plan for the National Health System of Spain. Madrid: Spanish Ministry of Health, Social Policy and Equality; 2009.
43. Spanish Ministry of Health, Social Policy and Equality. Stroke Strategy of the Spanish National Health System. Madrid: Spanish Ministry of Health, Social Policy and Equality; 2009.
44. Spanish Ministry of Health, Social Services and Equality. Strategy for Addressing Chronicity in the Spanish National Health System. Madrid: Spanish Ministry of Health, Social Services and Equality; 2012.